|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 271/06 | (2006.01) |
| C07D 285/08 | (2006.01) | ||
| A61K 31/4245 | (2006.01) | ||
| A61K 31/433 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61P 31/10 | (2006.01) | ||
| A61P 31/12 | (2006.01) |
| (11) | Patento numeris | 3363790 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18162983.3 |
| Europos patento paraiškos padavimo data | 2014-09-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-19 |
| (46) | Apibrėžties vertimo paskelbimo data | 2020-05-11 |
| (30) | Numeris | Data | Šalis |
| 4011CH2013 | 2013-09-06 | IN |
| (72) |
SASIKUMAR, Pottayil Govindan Nair, IN
RAMACHANDRA, Muralidhara, IN
NAREMADDEPALLI, Seetharamaiah Setty Sudarshan, IN
|
| (73) |
Aurigene Discovery Technologies Limited,
39-40 KIADB Industrial Area Electronic City Phase-II Hosur Road, Bangalore, Karnataka 560100,
IN
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 1,2,4-Oksadiazolo dariniai, kaip imunoduliatoriai |
| 1,2,4-OXADIAZOLE DERIVATIVES AS IMMUNOMODULATORS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-08-25 | 12 | 289.00 EUR |
| 2026-09-05 |